Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEvaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 99
- Run by
- Peking University Third Hospital
See details and how to joinNCT06277531 - Early phase 1Taking peopleStudy of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 56
- Run by
- Ruijin Hospital
See details and how to joinNCT06577532 - No phaseTaking peopleClinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06515587 - Phase 2Taking peopleCadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06532617 - Phase 2Taking peopleA Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06962267 - No phaseNot yet taking people in ChinaClinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 10
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06960122 - Phase 2Taking peopleThe Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
- Where
- Changsha, Shanghai
- Age
- 18 years to 80 years
- People
- 90
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06946901 - No phaseTaking peopleRaman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
- Where
- Hangzhou, Nanchang, Shanghai
- People
- 600
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06822413 - No phaseNot yet taking people in ChinaEvaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 66
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06941987 - No phaseTaking people18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06937112 - Phase 1Taking peopleA Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
- Where
- Tianjin
- Age
- 18 years to 70 years
- People
- 21
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06760364 - Phase 2Not yet taking people in ChinaAdebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 46
- Run by
- Jin Xu
See details and how to joinNCT06916975 - Phase 1Not yet taking people in ChinaA Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Akeso
See details and how to joinNCT06913218 - Phase 2Taking peopleTamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
- Where
- Shanghai
- Age
- 14 years to 80 years
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06914674 - Phase 4Not yet taking people in ChinaMaintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 464
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06779318 - No phaseTaking peopleClinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.
- Where
- Wuwei
- Age
- 18 years to 80 years
- People
- 62
- Run by
- Gansu Wuwei Tumor Hospital
See details and how to joinNCT06840067 - Phase 3Taking peopleClinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
- Where
- Harbin, Jinan, Shanghai
- Age
- 18 years to 75 years
- People
- 512
- Run by
- Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
See details and how to joinNCT05653453 - Phase 1/2Not yet taking people in ChinaPersonalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Zhejiang University
See details and how to joinNCT06888648 - Phase 1/2Not yet taking people in ChinaPersonalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Zhejiang University
See details and how to joinNCT06888674 - No phaseTaking peopleAI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
- Where
- Jiaxing, Ningbo, Shanghai
- Age
- 18 years and over
- People
- 5,000
- Run by
- Changhai Hospital
See details and how to joinNCT06638866 - Phase 1/2Not yet taking people in ChinaA Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer
- Where
- Changsha
- Age
- 18 years and over
- People
- 10
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT06866977 - Phase 1Taking peopleNeoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 43
- Run by
- Sichuan University
See details and how to joinNCT06344156 - No phaseNot yet taking people in ChinaChemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).
- Where
- Shanghai
- Age
- 70 years to 85 years
- People
- 36
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06844773 - No phaseTaking peopleIrinotecan Liposome in Combination With Capecitabine
- Where
- Shenzhen
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Junjie Hang
See details and how to joinNCT06578052 - No phaseTaking peopleConstruction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
- Where
- Shanghai
- Age
- 18 years and over
- People
- 100
- Run by
- Zhaoshen Li
See details and how to joinNCT05737953